Stockscreener 앱 받기
10.25
0.10%
-0.010
시간 외 거래:
10.25
전일 마감가:
$10.26
열려 있는:
$10.3
하루 거래량:
1.05M
Relative Volume:
1.75
시가총액:
$592.02M
수익:
$1.12B
순이익/손실:
$55.30M
주가수익비율:
10.79
EPS:
0.95
순현금흐름:
$-30.30M
1주 성능:
+3.22%
1개월 성능:
-1.91%
6개월 성능:
-49.38%
1년 성능:
-13.65%
1일 변동 폭
$9.96
$10.38
1주일 범위
$9.20
$10.38
52주 변동 폭
$9.20
$21.48
Embecta Corp Stock (EMBC) Company Profile
명칭
Embecta Corp
전화
(862) 401-0000
주소
1209 ORANGE STREET, WILMINGTON
EMBC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
EMBC
Embecta Corp
|
10.25 | 592.02M | 1.12B | 55.30M | -30.30M | 0.95 |
|
ISRG
Intuitive Surgical Inc
|
540.60 | 189.82B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
177.27 | 49.98B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
89.30 | 44.00B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
255.88 | 37.05B | 5.02B | 1.31B | 1.56B | 8.91 |
|
WST
West Pharmaceutical Services Inc
|
221.22 | 16.36B | 2.90B | 467.20M | 306.90M | 6.37 |
Embecta Corp Stock (EMBC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-10 | 개시 | Mizuho | Neutral |
| 2024-12-02 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2024-11-27 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2023-10-20 | 개시 | Wolfe Research | Peer Perform |
| 2023-01-06 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2022-09-08 | 개시 | BTIG Research | Neutral |
| 2022-08-01 | 개시 | Morgan Stanley | Equal-Weight |
| 2022-06-21 | 개시 | BofA Securities | Underperform |
모두보기
Embecta Corp 주식(EMBC)의 최신 뉴스
Embecta raises adjusted EBITDA margin outlook for FY 2025 amid restructuring and debt reduction - MSN
Pen Needles Market to Hit USD 3.08 Billion by 2030 with 9.2% CAGR | MarketsandMarkets™NORTHEAST - NORTHEAST - NEWS CHANNEL NEBRASKA
Transcript : Embecta Corp. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 01 - MarketScreener
InvestingPro’s bearish call on Embecta proves accurate with 48% decline By Investing.com - Investing.com Nigeria
Embecta stock hits 52-week low at $10.26 amid market challenges By Investing.com - Investing.com South Africa
Embecta stock hits 52-week low at $10.26 amid market challenges - Investing.com Australia
BofA cuts Embecta stock price target to $18 from $20 By Investing.com - Investing.com South Africa
BofA cuts Embecta stock price target to $18 from $20 - Investing.com India
(EMBC) Technical Data - news.stocktradersdaily.com
Embecta Corp (EMBC) Stock Price Down 6.22% on May 28 - GuruFocus
embecta to Participate in Investor Events - The Manila Times
embecta to Participate in Investor Events - GlobeNewswire Inc.
Independent Non-Executive Chairman of Embecta Picks Up 13% More Stock - Yahoo Finance
Insider Buying: David Melcher Acquires 10,000 Shares of Embecta Corp (EMBC) - GuruFocus
Director Makes Bold Move with Major Stock Purchase in Embecta Corporation! - TipRanks
Embecta (EMBC): Mizuho Maintains Rating, Adjusts Price Target | - GuruFocus
Embecta (EMBC): Mizuho Maintains Rating, Adjusts Price Target | EMBC Stock News - GuruFocus
Embecta (EMBC) Price Target Cut by Mizuho Amid Flat Sales Outlook | EMBC Stock News - GuruFocus
Embecta price target lowered to $25 from $26 at BTIG - TipRanks
Embecta Corporation’s Strategic Transition and Financial Outlook: A Buy Rating Based on Growth Initiatives and Attractive Valuation - TipRanks
Embecta Corp (EMBC) Shares Gap Down to $10.85 on May 22 - GuruFocus
Embecta stock touches 52-week low at $10.82 amid market challenges - Investing.com Australia
Embecta eyes shift from insulin delivery to broader medical supplies focus - Drug Delivery Business
Transcript : Embecta Corp.Analyst/Investor Day - marketscreener.com
Embecta stock touches 52-week low at $10.82 amid market challenges By Investing.com - Investing.com South Africa
Embecta (NASDAQ:EMBC) Has Announced A Dividend Of $0.15 - simplywall.st
Embecta Unveils Strategy at Analyst and Investor Day - TipRanks
Embecta (NASDAQ:EMBC) Has Affirmed Its Dividend Of $0.15 - Yahoo Finance
Embecta Corp. Re-Affirms Earnings Guidance for the Fiscal Year 2025 - marketscreener.com
embecta to Showcase Phased Approach for Value Creation and Present Long Range Financial Plan at 2025 Analyst and Investor Day - The Manila Times
Embecta Corp. Hosts Inaugural Analyst and Investor Day to Outline Long-Term Financial Plan and Strategic Priorities - Nasdaq
embecta to Showcase Phased Approach for Value Creation and - GlobeNewswire
embecta recognized as Healthcare Technology Company of the Year - The Healthcare Technology Report.
Cautious Outlook on Embecta Corporation Amidst Unclear Growth Catalysts and Margin Concerns - TipRanks
Embecta Corp (EMBC) Shares Down 2.83% on May 19 - GuruFocus
How to Take Advantage of moves in (EMBC) - news.stocktradersdaily.com
Embecta Corp. (NASDAQ:EMBC) Q2 2025 Earnings Call Transcript - MSN
Embecta: Not Nearly As Cheap As The 4x Forward P/E Ratio Would Imply (NASDAQ:EMBC) - Seeking Alpha
Embecta restructures again, outlines tariff costs - MedTech Dive
Morgan Stanley Adjusts Price Target on Embecta to $15 From $20, Maintains Equalweight Rating - marketscreener.com
Positive Outlook for Embecta Corporation Amid Strong Financial Performance and Strategic Initiatives - TipRanks
Cautious Optimism for Embecta Corporation Amid Challenging Environment and Hold Rating - TipRanks
Embecta Q2 2025 slides: Revenue decline offset by margin improvement and debt reduction - Investing.com
Earnings call transcript: Embecta Q2 2025 beats EPS forecast, stock dips - Investing.com Nigeria
Embecta Corp (EMBC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Embecta Corp 주식 (EMBC) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Melcher David F | Director |
Feb 25 '25 |
Buy |
13.67 |
13,000 |
177,646 |
76,681 |
| Morris Milton Mayo | Director |
Feb 13 '25 |
Sale |
16.38 |
3,100 |
50,783 |
36,133 |
0.46%
0.05%
자본화:
|
볼륨(24시간):